openPR Logo
Press release

Bacterial Conjunctivitis Drugs Market 2023: Growth Factors, Opportunities, Ongoing Trends and Key Players 2033

01-31-2023 09:08 AM CET | Health & Medicine

Press release from: Persistence Market Research

Bacterial Conjunctivitis Drugs Market 2023: Growth Factors,

The global bacterial conjunctivitis drugs market is expected to register a healthy growth rate in the coming years, driven by increased incidence of the condition and rising adoption of modern treatments. 

Bacterial conjunctivitis - also known as pink eye - is a common eye infection caused by various types of bacteria. It is typically characterized by redness and swelling of the eyes along with formation of pus which leads to severe itching, pain and difficulty in vision.

Various drugs are available for treating this condition including antibiotics, steroids, ophthalmic solutions and cycloplegics among others. These drugs are generally recommended depending on the severity of symptoms and potential underlying causes.

Request For Free Sample Report of "Bacterial Conjunctivitis Drugs Market"@ https://www.persistencemarketresearch.com/samples/5192

Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis is one of the most commonly observed eye problems across all age groups, generally caused by bacteria such as Staphylococcus aureus, Moraxella lacunata, Haemophilus influenza, and others (e.g. Chlamydia trachomatis, Proteus mirabilis, etc.).

As reported by Healio (specialty medical news and journal publisher), approximately 5 million acute bacterial conjunctivitis cases are reported in the U.S. each year. Thus, high prevalence of bacterial conjunctivitis in the country demands effective medications, thereby driving the growth of the bacterial conjunctivitis drugs market in the U.S.However, despite the increasing incidence of bacterial conjunctivitis, the overall bacterial conjunctivitis market in the U.S. is likely to witness negative growth due to the patent expirations of major blockbuster drugs such as Vigamox, Moxeza, Zymaxid, and Besivance in the next few years.

Companies

Actavis plc.
Akorn, Inc.
Bayer AG.
Hoffmann-La Roche, Ltd.
Merck & Co., Inc.
Novartis AG.
Perrigo Company plc, Pfizer, Inc.
Santen Pharmaceutical Co., Ltd.

Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/5192

The U.S. bacterial conjunctivitis drugs market is segmented as follows:

U.S. Bacterial Conjunctivitis Drugs Market, by Drug Class

Fluoroquinolones

Ciprofloxacin

Ofloxacin

Levofloxacin

Moxifloxacin

Gatifloxacin

Besifloxacin

Aminoglycosides

Tobramycin

Gentamycin

Macrolides

Erythromycin

Azithromycin

Others

 U.S. Bacterial Conjunctivitis Drugs Market, Pipeline Assessment

Vancomycin Ophthalmic Ointment

Early Stage (Phase I and Phase II trials) - Tabular Representation

Request Customization @ https://www.persistencemarketresearch.com/request-customization/5192

Key Questions Answered in This Report.

What are the Roadblocks for Bacterial Conjunctivitis Drugs Market Suppliers?
What are the Key Opportunities for Bacterial Conjunctivitis Drugs Market Manufacturers?
How is Focus on Safety Influencing Bacterial Conjunctivitis Drugs Market Demand?
What is the Regulatory Impact on Global Sales of Bacterial Conjunctivitis Drugs Market?
Which Region Offers the Largest Opportunity for Sales of Bacterial Conjunctivitis Drugs Market?
Where Does the U.S. Stand in the Market for Bacterial Conjunctivitis Drugs Market?
What Is the Outlook for Bacterial Conjunctivitis Drugs Market Manufacturers in China?
Why is Germany a Lucrative Market for Bacterial Conjunctivitis Drugs Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Bacterial Conjunctivitis Drugs Market?
Why is There High Demand for Tires in Bacterial Conjunctivitis Drugs Market?
Why are Sales of Bacterial Conjunctivitis Drugs Market Surging?

For More Premium Insights, Check out the Link:

Cell Counting Market - https://www.medgadget.com/2023/01/global-cell-counting-market-rising-burden-of-chronic-illness-to-drive-the-demand-for-cell-counting-techniques-pmr.html

Corneal Implants Market - https://www.medgadget.com/2023/01/corneal-implants-market-2023-a-significant-rise-in-demand-for-collagen-based-bio-engineered-synthetic-corneas-is-attributed-to-their-popularity.html

Cosmetic Cdmo Market - https://www.medgadget.com/2023/01/cosmetic-cdmo-market-is-predicted-to-surge-ahead-at-a-cagr-of-6-to-reach-us-37-9-bn-by-the-end-of-2032-swiss-american-cdmo-pierre-fabre-group-zymo-cosmetics-fareva.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bacterial Conjunctivitis Drugs Market 2023: Growth Factors, Opportunities, Ongoing Trends and Key Players 2033 here

News-ID: 2905983 • Views:

More Releases from Persistence Market Research

Antimicrobial Additives Market Expected to Grow at 7.8% CAGR Between 2025 and 2032 - Persistence Market Research
Antimicrobial Additives Market Expected to Grow at 7.8% CAGR Between 2025 and 20 …
The antimicrobial additives market has evolved into a critical segment within the global specialty chemicals and materials landscape, driven by the growing need to control microbial contamination across healthcare, food packaging, construction, automotive, and consumer goods industries. Antimicrobial additives are incorporated into materials such as plastics, coatings, textiles, and papers to inhibit the growth of bacteria, fungi, and other microorganisms throughout a product's lifecycle. Their role has expanded beyond basic
Smart Manufacturing Market Valued at US$394.4 Billion in 2025, Expected to Reach US$999.0 Billion by 2032 | Persistence Market Research
Smart Manufacturing Market Valued at US$394.4 Billion in 2025, Expected to Reach …
The smart manufacturing market represents a fundamental transformation in how goods are designed, produced, monitored, and delivered across global industries. It combines advanced digital technologies such as industrial Internet of Things (IIoT), artificial intelligence (AI), machine learning, robotics, cloud computing, digital twins, and advanced analytics to create highly connected, automated, and intelligent production environments. Unlike traditional manufacturing, smart manufacturing enables real-time decision-making, predictive maintenance, adaptive production planning, and end-to-end visibility
Oligonucleotide Synthesis Market Forecast Signals Strong Expansion During 2025-2032 | Persistence Market Research
Oligonucleotide Synthesis Market Forecast Signals Strong Expansion During 2025-2 …
The oligonucleotide synthesis market has evolved from a niche research-support function into a strategic pillar of modern biotechnology and pharmaceutical development. Oligonucleotides-short, synthetically produced DNA or RNA sequences-are indispensable in applications ranging from basic genetic research and molecular diagnostics to advanced therapeutics such as antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and RNA- and DNA-based vaccines. As precision medicine continues to reshape healthcare, the ability to reliably synthesize high-quality, customized
Genome Editing Market Demand Surges Across Biotechnology and Pharmaceutical Sectors - Persistence Market Research
Genome Editing Market Demand Surges Across Biotechnology and Pharmaceutical Sect …
The genome editing market has emerged as one of the most transformative segments within modern biotechnology, reshaping how scientists, clinicians, and agricultural innovators approach genetic modification. Genome editing refers to a suite of technologies that allow precise alterations to DNA within living organisms, enabling the correction of genetic defects, enhancement of desirable traits, and development of advanced therapeutic solutions. Over the past decade, breakthroughs such as CRISPR/Cas9, base editing, and

All 5 Releases


More Releases for Bacterial

Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market? The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training. The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can
02-07-2017 | Health & Medicine
TMR
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as